Media Room
Second quarter 2023 results
Second quarter 2023 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Press releases
October 2, 2023
Media Update: Sanofi presents new data from robust MS clinical pipeline exploring multiple approaches to address important unmet patient needs
September 26, 2023
Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review
Contact our media team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
For any other request, please call the switchboard: +33 1 53 77 40 00
Publications
Half Year 2023 Financial Report XBRL Package
Half Year 2023 Financial Report
First quarter 2023 results
Fourth quarter and full year 2022 results
Email Alerts
Subscribe to our email alerts to receive our press releases.